Roscovitine (CYC202)

For research use only.

Catalog No.S1153 Synonyms: Seliciclib, R-roscovitine

92 publications

Roscovitine (CYC202) Chemical Structure

CAS No. 186692-46-6

Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 240 In stock
USD 185 In stock
USD 323 In stock
USD 592 In stock
USD 1222 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Roscovitine (CYC202) has been cited by 92 publications

Purity & Quality Control

Choose Selective CDK Inhibitors

Biological Activity

Description Roscovitine (CYC202, Seliciclib, R-roscovitine) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM in cell-free assays. It shows little effect on CDK4/6. Phase 2.
Targets
CDK5/p35 [1]
(Cell-free assay)
Cdc2/CyclinB [1]
(Cell-free assay)
CDK2/CyclinA [1]
(Cell-free assay)
CDK2/CyclinE [1]
(Cell-free assay)
ERK2 [1]
(Cell-free assay)
0.16 μM 0.65 μM 0.7 μM 0.7 μM 14 μM
In vitro

Roscovitine displays high efficiency and high selectivity towards some cyclin-dependent kinases with IC50 of 0.65, 0.7, 0.7 and 0.16 μM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E and cdk5/p53, respectively. [1] Roscovitine reversibly inhibits the prophaselmetaphase transition in the micromolar range of starfish oocytes and sea urchin embryos, inhibits in vitro M-phase-promoting factor activity and in vitro DNA synthesis in Xenopus egg extracts, and suppresses the proliferation of mammalian cell lines with an average IC50 of 16 μM. [1] In mesangial cells, Roscovitine results in a dose-dependent reduction of CDK2 activity that at concentrations of 7.5, 12.5 and 25 mM, Roscovitine causes a 25, 50% and 100% decrease in CDK2 activity, respectively. [2] A recent study shows that Roscovitine inhibits cdk5 kinase activity, cell proliferation, multicellular development, and cdk5 nuclear translocation in Dictyostelium discoideum, without affecting the expression of cdk5 protein during axenic growth. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LB771-HNC NW\RNIpZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoTJTWM2OD12OD65NlEzKM7:TR?= NH;rWnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LB2241-RCC MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn\xTWM2OD12OD62NlAzKM7:TR?= NHjuPIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
DU-4475 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlnYTWM2OD12OD60PVM4KM7:TR?= NEC0R209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LB2518-MEL Mn3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHXTWM2OD12Nz6wOFQ5KM7:TR?= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H209 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkixTWM2OD12Nj6wNVE2KM7:TR?= NVTHd5ZuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
CGTH-W-1 M4XXcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDpRYFKSzVyPUS0Mlk3QTdizszN M2TTWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MS-1 NX7TNmVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfRUFRKSzVyPUSyMlg6OyEQvF2= NX[xZWpVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
GI-ME-N NEHFT4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{D6RmlEPTB;NEKuOlY4OSEQvF2= MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
DG-75 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XmXGlEPTB;NEKuOlU1PiEQvF2= M{fDbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MLMA MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3LiU2lEPTB;NEKuNlc5PyEQvF2= NGLTZZk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
HT MoC5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTR{LkCwNlgh|ryP MnTEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
LC-1F NX;LZlhmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37kfWlEPTB;NEGuOVcxPSEQvF2= MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H1882 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NELPeGxKSzVyPUSwMlU6QThizszN MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NTERA-S-cl-D1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVnJR|UxRTN7LkW4OFIh|ryP MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H345 M1vCVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYeydHp7UUN3ME2zPE46OTB4IN88US=> NELmeYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MONO-MAC-6 Mn\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUKxT|VpUUN3ME2zPE4zPDd5IN88US=> NUDCNWdTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
RS4-11 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF61WHJKSzVyPUO3MlcxPjlizszN Mn[1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
ML-2 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWfJR|UxRTN5Lk[3NVIh|ryP MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
OPM-2 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEfwNo1KSzVyPUO3MlI6PDlizszN M{Pib|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LU-139 NGPjb5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTTTWM2OD1|Nz6xPFU3KM7:TR?= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
COLO-684 Ml3BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXXJR|UxRTN5LkCxNkDPxE1? M{TJXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MOLT-4 MkjBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHLsVmxKSzVyPUO2MlMzPzZizszN MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
TE-6 MmDRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTN4LkOyOFYh|ryP MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
TE-441-T MlyzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmT2TWM2OD1|Nj6xNVQ5KM7:TR?= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
IMR-5 MlvvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHpTWM2OD1|NT6zNVM6KM7:TR?= NFz2N3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
K5 M4\RTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFK2TpNKSzVyPUO1MlA5PjFizszN M17zUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
TE-10 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTN2Lkm0NlIh|ryP M3\hN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-H2141 NXrXSZJUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoX5TWM2OD1|ND62OVM{KM7:TR?= NX3yfW0zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KGN M{DBeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTN2LkK1NlQh|ryP M2jKUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LP-1 M1f4[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mk\sTWM2OD1|Mz64PVA5KM7:TR?= NVr0VYN3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H64 M3PZcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzCTWM2OD1|Mz64OVk4KM7:TR?= M{n1ZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
RKO NV3qZnNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX\GfmRHUUN3ME2zN{42QTZ7IN88US=> M1;MNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCI-H526 M1rvc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmj4TWM2OD1|Mz60PVM3KM7:TR?= MmfrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
GOTO NXP4TGJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXz1e4FjUUN3ME2zNk46OTJ7IN88US=> M13EZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
Calu-6 M1HQWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGXuSlRKSzVyPUOyMlQ4PDVizszN MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
LOUCY MofYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoLxTWM2OD1|Mj6xNlU{KM7:TR?= M2fSbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SK-N-FI MkCzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTNzLke1N|Uh|ryP MmrKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
SIG-M5 MljnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTNzLk[4N|Mh|ryP NF\5[VA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NKM-1 MmDkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVjLU4pCUUN3ME2zNU4yOzl5IN88US=> MlPrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-SNU-1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MljFTWM2OD1|MT6xNFU6KM7:TR?= NVrJOoNORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NCI-H82 NFPLTWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWLJR|UxRTNzLkCxN|Uh|ryP MlLEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
NCI-H510A M1jHNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIKzV3hKSzVyPUOwMlA{OjlizszN MnLvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
ES3 NXv6Nm05T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVzJR|UxRTJ7Lkm1PFIh|ryP NV\Y[pRlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
BB30-HNC M1nDS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HrcGlEPTB;MkmuPVQ5OyEQvF2= NVr3fGM6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KM12 NX:2fVdXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXrTWM2OD1{OT62NlM6KM7:TR?= Mn7ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
GI-1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVHUUWpVUUN3ME2yPU4xOTF|IN88US=> MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NOS-1 MnTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTJ6Lkm3N|Mh|ryP NVTFW|dLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
TE-8 M1KxZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTJ6LkmwPEDPxE1? NI\Dd3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
TE-9 NXK4NIZbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXGyeYdUUUN3ME2yPE44QTZ7IN88US=> MkXFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HL-60 NF3YbYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mm\2TWM2OD1{Nz65PFY6KM7:TR?= MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
QIMR-WIL M2e3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fxV2lEPTB;MkeuPVE1PCEQvF2= NWXjV|drRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KARPAS-299 NHPIWVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml3rTWM2OD1{Nj64OlQ3KM7:TR?= MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KURAMOCHI NEjJdYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnaO4huUUN3ME2yOk45ODh{IN88US=> Ml;2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
BL-41 M2\tSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWLJR|UxRTJ3Lkm1PVch|ryP MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NCI-H2126 NVu5U3ZYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF;BTXRKSzVyPUK1MlY2OjlizszN M2HRdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
HOP-62 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYK1VY85UUN3ME2yOU41PDJ3IN88US=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
IST-SL2 M1jzUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEHKOWdKSzVyPUK0MlU{PDNizszN Mli2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HH MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYL4cmVvUUN3ME2yOE4{QDF7IN88US=> M37OT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
LS-513 NWfNNYNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXr4V246UUN3ME2yN{42OTd7IN88US=> NIfVWGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
EB-3 MmPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2XMVGlEPTB;MkOuNVg{OSEQvF2= M374eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ACN NWHHNWlXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYrJR|UxRTJzLkOzPFkh|ryP MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
NOMO-1 M4\zN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGOzSFRKSzVyPUKxMlIxODhizszN NWDVNpllRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
ES8 NF7LV|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{nZ[GlEPTB;MkGuNFYh|ryP NXjyN2dORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
CESS NXvuXYlIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TUOWlEPTB;MkCuPFU1QSEQvF2= M1LRU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
BL-70 NH\zVY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY\JR|UxRTJyLkOyO|Qh|ryP NGHWOIc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
MHH-PREB-1 M4nTfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7TOWk1UUN3ME2yNE4xOzV4IN88US=> NWjVXWV1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
BC-1 NGK1XIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NET6W29KSzVyPUG5MlEyQThizszN NI[xWok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LC4-1 NW\iRXc3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2X2[mlEPTB;MUiuPFc{PCEQvF2= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
COLO-320-HSR M1XjUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUjiNFFsUUN3ME2xPE44Pjh6IN88US=> NYryU2ZqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
A101D MmfWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTF6LkOyNFgh|ryP MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
BC-3 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDCTWM2OD1zOD6wN|A2KM7:TR?= M3;3XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
TGW NVvNdVhrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XCU2lEPTB;MUeuPFEzPCEQvF2= NXS1RoQ6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
JAR NEC4[JlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4LsemlEPTB;MUeuNFE2OiEQvF2= MnrWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
HD-MY-Z MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWPWbmFDUUN3ME2xOk45OjR4IN88US=> NHzkOm49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
NCI-H1304 Mn\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3qzTGlEPTB;MU[uN|YxOSEQvF2= NI\JW|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
OS-RC-2 MmHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPMNIVKSzVyPUG1Mlg{QDJizszN MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
OCI-AML2 NFr6WoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoDZTWM2OD1zNT62OFgzKM7:TR?= NUDLUXJURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
HCC1599 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfhV3pLUUN3ME2xOE42QTd3IN88US=> M2nQOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
SCC-3 M{nodGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3EdFVtUUN3ME2xOE4zQTV4IN88US=> Mk[3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
RPMI-6666 NULJfWxFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmjaTWM2OD1zMz65NVIyKM7:TR?= M2ryXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
MEG-01 NUjlZ5J3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHseXFKSzVyPUGzMlg{PzlizszN MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
Raji MoixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4PnOWlEPTB;MUOuO|g6PCEQvF2= M1jKe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
RPMI-8402 NITac2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXfmN|h5UUN3ME2xN{43OjZ{IN88US=> M2WyfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
GCIY NVTzd|dKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{LnOWlEPTB;MUKuPFYyOyEQvF2= MlewQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
697 M3vq[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MljFTWM2OD1zMj62NFA4KM7:TR?= MnnzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
D-247MG MnzzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkCyTWM2OD1zMj6zOVE3KM7:TR?= NVjtUZAyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
NB1 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LkeWlEPTB;MUKuN|MxQCEQvF2= NFvNVIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
COR-L279 M1\jVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGHhXXlKSzVyPUGyMlI6ODdizszN NEjuUlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
LB831-BLC M4rTTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYGyTZU4UUN3ME2xNU42PjJ2IN88US=> M{n2TVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
ST486 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnXzTWM2OD1zMD6zOVEh|ryP MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
SK-UT-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\KTI5KSzVyPUGwMlM2KM7:TR?= NEDCPWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwyPDd4Mj:nQnNCVkeHUkyvZV4>
BB65-RCC M2f2bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2DsZmlEPTB;OT65O|Q6PSEQvF2= NX6xW5pURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
KARPAS-422 NX\ab2hvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjoSmJKSzVyPUmuPVY{OzZizszN M4DXfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
Becker NH:2eFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MY\JR|UxRTlwNE[wPFIh|ryP MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyxOFc3Oi9pPmPBUmdGWjxxYU6=
KS-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mke3TWM2OD17LkS1O|g2KM7:TR?= MnjCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
JiyoyeP-2003 M2\3d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGfMXmZKSzVyPUiuOVAzPjRizszN M1fCNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
NCCIT M2DpTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\QTWM2OD15LkW1OFgzKM7:TR?= NUPHe|l[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOTR5NkKvK|5USU6JRWK8M4E,
MRK-nu-1 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{f6d2lEPTB;Nz6xNlk3QSEQvF2= M2TlelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFE1PzZ{Lze+V2FPT0WUPD;hQi=>
A3-KAW NVrxXFF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUDJR|UxRTVwN{[xNVYh|ryP Ml[5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNVQ4PjJxJ{7TRW5ITVJ:L3G+
SK-N-MC M3LmcpFJXFNiYYPzZZk> MWXxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= MnPGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
LP-1 NYnqSop3SXCxcITvd4l{KGG|c3H5 M2ThSVMxKHWP NIHvR4Y{KGi{cx?= Mn;5TY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCOUD2xJINmdGy|IHH0JFMxKHWPIHHmeIVzKDNiaILzJJV{cW6pIGTVUmVNKHO2YXnubY5oKGK7IH\sc5ch[3m2b33leJJ6 M{nYflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
LP-1 NYW3RVNSS3m2b4TvfIlkcXS7IHHzd4F6 NWTTd2RPOjBidH:gN|AhfU1? M3T5[lI1KGi{cx?= MXvDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMVE0yKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDj[YxtKH[rYXLpcIl1gSCjdDCyNEB1dyB|MDD1UUB1emWjdHXkJIZweiB{NDDodpMh\m:ubH;3[YQh[nlid3HzbI92fCCvZXHzeZJm\CCjZoTldkB1d3SjbDC3NkBpenNiZ4Lve5RpKHCncnnv[EBidGGvYYKgZox2\SCjc4PhfUBz\WyjdHn2[UB1dyClb370do9t MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
LP-1 NYroSHJXSXCxcITvd4l{KGG|c3H5 NGfINoU{OCC3TR?= MUGxMlUhcHK| NYjBVIJyUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDMVE0yKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p NHvadGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
LP-1 NVXHUIprSXCxcITvd4l{KGG|c3H5 M{LJSFMxKHWP MkLJN{BpenN? MWPJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKEySLUGgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKE2lbD2xJJBzd3SnaX6gcIV3\WxiYYSgN|AhfU1iYX\0[ZIhOyCqcoOgZpkhcW2vdX7vZoxwfHSrbne= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
LP-1 M{LLXWFxd3C2b4Ppd{Bie3OjeR?= NG\q[3g{OCC3TR?= MkPwN{B1dyB3IHjydy=> M3PwO2lv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTGCtNUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCuZY\lcEBw\iClbHXheoVlKFCDUmCgZZQhOzBidV2gZYZ1\XJiMzD0c{A2KGi{czDifUBqdW23bn;icI91fGmwZx?= MnLrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 M1nzRWFxd3C2b4Ppd{Bie3OjeR?= MmjhN|AhfU1? Ml\DOUBpenN? M37TfGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gcIV3\Wxib3[gZ4xm[X[nZDDQRXJRKGG2IEOwJJVOKGGodHXyJFUhcHK|IHL5JIludXWwb3Lsc5R1cW6p M3S5OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 M2DBTmFxd3C2b4Ppd{Bie3OjeR?= MXKzNEB2VQ>? M4L0b|EvPSCqcoO= MXXJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KG[jc4Sgd4xwfyCvaXfyZZRqdmdiaInw[ZJxcG:|cHjvdplt[XSnZDDSUmEheG:ueX3ldoF{\SB{TzDmc5JuKGG2IEOwJJVOKGGodHXyJFEvPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= MmfCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
RPM18226 MX7BdI9xfG:|aYOgZZN{[Xl? MWWzNEB2VQ>? NE\r[mEyNjViaILz Mny5TY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCUUF2xPFIzPiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[gVm5CKHCxbInt[ZJie2ViMjDwbI9{eGixc3XybY5mKDJibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgNU42KGi{czDifUBqdW23bn;icI91fGmwZx?= NUL0dZBJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
RPM18226 NFnt[VlCeG:ydH;zbZMh[XO|YYm= M{npXVMxKHWP MkPtN{BpenN? MYPJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDNZ4wuOSCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
RPM18226 Moi2RZBweHSxc3nzJIF{e2G7 M3j4VVMxKHWP Mk[5N{B1dyB3IHjydy=> MWXJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKFKSTUG4NlI3KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHzleoVtKG:oIHPs[YF3\WRiUFHSVEBifCB|MDD1UUBi\nSncjCzJJRwKDViaILzJIJ6KGmvbYXuc4Jtd3S2aX7n NHTKfJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUm1PFU5QSd-MUW5OVg2QDl:L3G+
NCI-H929 NInyW4lCeG:ydH;zbZMh[XO|YYm= MY[zNEB2VQ>? NUnhe4hOOyCqcoO= NGjWRZpKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IHPoZY5o\XNiaX6gXGlCWCCycn;0[YlvKGyndnXsJIF1KDNyIIXNJIFnfGW{IEOgbJJ{KGK7IHntcZVvd2Kub4T0bY5o NX3DdoFkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 MYTBdI9xfG:|aYOgZZN{[Xl? NHrFTYc{OCC3TR?= NVHpUm51OyCqcoO= M1nTUWlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmeyCrbjDzeZJ3cX[rbjDwdo91\WmwIHzleoVtKGG2IEOwJJVOKGGodHXyJFMhcHK|IHL5JIludXWwb3Lsc5R1cW6p M2TCeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
RPM18226 MW\BdI9xfG:|aYOgZZN{[Xl? NVPseVA2OzBidV2= MV6zJIhzew>? M4nBdmlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iUmDNNVgzOjZiY3XscJMh[XRiM{CgeW0h[W[2ZYKgN{BpenNidYPpcochXFWQRVygd5RicW6rbnegZpkh\myxdzDjfZRwdWW2com= MkfGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 NV:2WWFqSXCxcITvd4l{KGG|c3H5 NHjLOZo{OCC3TR?= MoT3NU42KGi{cx?= MW\JcoR2[3Srb36gc4Yh[XCxcITvd4l{KGmwIHj1cYFvKE6FST3IPVI6KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDSUmEheG:ueX3ldoF{\SB{IIDoc5NxcG:|ZYLpcoUhOiCuZY\lcEBifCB|MDD1UUBi\nSncjCxMlUhcHK|IHL5JIludXWwb3Lsc5R1cW6p MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 M{POZmFxd3C2b4Ppd{Bie3OjeR?= NUTwN5p[OzBidV2= NYHG[HVPOS53IHjydy=> NEHDN41KdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IHTldIhwe3Cqb4L5cIF1cW:wIH;mJJBT[iCjdDDTNlQ6N1R{NUKgZZQhOzBidV2gZYZ1\XJiMT61JIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? NYDSV45MRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 M322OmN6fG:2b4jpZ4l1gSCjc4PhfS=> M1qzRVIxKHSxIEOwJJVO M4X1V|E3KGi{cx?= MVfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4Yh[2WubDD2bYFjcWyrdImgZZQhOjBidH:gN|AhfU1idILlZZRm\CCob4KgNVYhcHK|IH\vcIxwf2WmIHL5JJdie2ixdYSgcYVie3W{ZXSgZYZ1\XJidH;0ZYwhPzJiaILzJIdzd3e2aDDw[ZJqd2RiYXzhcYFzKGKudXWgZZN{[XlicnXsZZRqfmVidH:gZ49vfHKxbB?= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NXXaOGZlSXCxcITvd4l{KGG|c3H5 MmfxN|AhfU1? MV2zJIhzew>? M3nCVGlv\HWldHnvckBw\iCjcH;weI9{cXNiaX6gbJVu[W5iTlPJMWg6OjliY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJG1kdC1zIIDyc5RmcW5ibHX2[Ywh[XRiM{CgeW0h[W[2ZYKgN{BpenNiYomgbY1ufW6xYnzveJRqdmd? M1uyVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3OUW4OVg6Lz5zNUm1PFU5QTxxYU6=
NCI-H929 NEnPc4FCeG:ydH;zbZMh[XO|YYm= MVyzNEB2VQ>? MmLTN{BpenN? NFvneJRKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IHPoZY5o\XNiaX6gRoNtNTJicILveIVqdiCuZY\lcEBifCB|MDD1UUBi\nSncjCzJIhzeyCkeTDpcY12dm:kbH;0eIlv\w>? MmHYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV7NUi1PFkoRjF3OUW4OVg6RC:jPh?=
NCI-H929 MVTBdI9xfG:|aYOgZZN{[Xl? NV:zTXpEOzBidV2= M2HMNlMhcHK| NUH3cYdwUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjdDCzNEB2VSCjZoTldkA{KGi{czD1d4lv\yCWVV7FUEB{fGGrbnnu[{BjgSCobH;3JIN6fG:vZYTyfS=> MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 NVL4cmU6SXCxcITvd4l{KGG|c3H5 M4DjPFMxKHWP Mmr3NU42KGi{cx?= NWTrbnpVUW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDOR2kuUDl{OTDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gc4YhWk6DIIDvcJlu\XKjc3WgNkBxcG:|cHjvd4VzcW6nIEWgcIV3\WxiYYSgN|AhfU1iYX\0[ZIhOS53IHjyd{BjgSCrbX31co9jdG:2dHnu[y=> MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTl3OEW4PUc,OTV7NUi1PFk9N2F-
NCI-H929 Mn7VRZBweHSxc3nzJIF{e2G7 M2q5OlMxKHWP NWDNR4g{OS53IHjydy=> NFvuWnhKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m|IHnuJIh2dWGwIF7DTU1JQTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBJ\G1{IHzleoVtKGG2IEOwJJVOKGGodHXyJFEvPSCqcoOgZpkhcW2vdX7vZoxwfHSrbne= NUTVRVZLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
NCI-H929 MmPYRZBweHSxc3nzJIF{e2G7 NHjvb3Q{OCC3TR?= NW\5cpJ2OS53IHjydy=> MofJTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCQQ1mtTFkzQSClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCxZjDwOVMh[WOldX31cIF1cW:wIHH0JFMxKHWPIHHmeIVzKDFwNTDodpMh[nliaX3teY5w[myxdITpcoc> NX3JeY46RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW5OVg2QDlpPkG1PVU5PTh7PD;hQi=>
SK-N-MC NHX0Z5RyUFSVIHHzd4F6 MYDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= M33LR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEiwO|A{Lz5{MUC4NFcxOzxxYU6=
HCT116 NWiwUWFkTnWwY4Tpc44h[XO|YYm= MXyzNEB1dyB2MDD1cY9tN0x? MnXmNlQhcHK| MYXJcohq[mm2aX;uJI9nKGO7Y3zpckBCKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCycn;0[YlvKGyndnXsJIF1KDNyIITvJFQxKHWvb3yvUEBi\nSncjCyOEBpenNiYomgbY1ufW6xYnzveJRqdmdiYX7hcJl{cXN? NF[4d|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HCT116 NEnMOZZHfW6ldHnvckBie3OjeR?= NWPtdFF[OzBidH:gOFAhfW2xbD;M MXGyOEBpenN? NWXBd5ROUW6qaXLpeIlwdiCxZjDjfYNtcW5iQjDpckBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gdJJwfGWrbjDs[ZZmdCCjdDCzNEB1dyB2MDD1cY9tN0xiYX\0[ZIhOjRiaILzJIJ6KGmvbYXuc4Jtd3S2aX7nJIFv[Wy7c3nz NIPZSlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HCT116 NEHrcYVHfW6ldHnvckBie3OjeR?= M4LjTFMxKHSxIESwJJVud2xxTB?= NYrT[4NrOjRiaILz MXHJcohq[mm2aX;uJI9nKGO7Y3zpckBFOSCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5icILveIVqdiCuZY\lcEBifCB|MDD0c{A1OCC3bX;sM2wh[W[2ZYKgNlQhcHK|IHL5JIludXWwb3Lsc5R1cW6pIHHuZYx6e2m| NIrk[W09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HCT116 NVTIV|VPTnWwY4Tpc44h[XO|YYm= M13V[|MxKHSxIESwJJVud2xxTB?= MoDINlQhcHK| NFewV2hKdmirYnn0bY9vKG:oIFPET|IhcW5iaIXtZY4hUEOWMUG2JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKHC{b4TlbY4hdGW4ZXygZZQhOzBidH:gOFAhfW2xbD;MJIFnfGW{IEK0JIhzeyCkeTDpcY12dm:kbH;0eIlv\yCjbnHsfZNqew>? NGW3e5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC4NFcxOyd-MkGwPFA4ODN:L3G+
HT-29 MV7GeY5kfGmxbjDhd5NigQ>? M{\1OlIvPSC2bzC0NEB2VQ>? M2r6V|I1KGi{cx?= NH\qOVBKdmirYnn0bY9vKG:oIILleIlvd2KuYYP0c41iKHC{b4TlbY4hcW5iaIXtZY4hUFRvMkmgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKGO7Y3zpckBCKGyndnXsJIF1KDJwNTD0c{A1OCC3TTDh[pRmeiB{NDDodpMh[nliaX3teY5w[myxdITpcoc> MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 MYnD[YxtKGO7Y3zlJIF{e2G7 Mo\yNlQhcHK| M3X5XWNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEd{L12gdIhie2ViYX\0[ZIhOjRiaILzJJV{cW6pIIDyc5Bq\Gm3bTDpc4Rq\GViYX7kJGJz\FVic4ThbY5qdmdiYomg[oxwfyCleYTvcYV1enl? NXPsNldtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
RPMI8226 NX3nZ|lFS2WubDDjfYNt\SCjc4PhfS=> MX6yOEBpenN? NXS3Wo9PS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWlCPSUiyNlYh[2WubIOgZZN{\XO|ZXSgZZMh[WOldX31cIF1cW:wIHH0JGczN01icHjhd4Uh[W[2ZYKgNlQhcHK|IIXzbY5oKHC{b4Dp[Il2dSCrb3Tp[IUh[W6mIFLy[HUhe3SjaX7pcoch[nliZnzve{BkgXSxbXX0dpk> MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 M3zzVGNmdGxiY4njcIUh[XO|YYm= NXnxSGQyOjRiaILz NV\RVYU{S2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBUKHCqYYPlJINmdGxicH;weYxifGmxbjDh[pRmeiB{NDDodpMhfXOrbnegdJJweGmmaYXtJIlw\GmmZTDhcoQhSnKmVTDzeIFqdmmwZzDifUBndG:5IHP5eI9u\XS{eR?= NW\afmJ5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
MCF7 MXLD[YxtKGO7Y3zlJIF{e2G7 MnXwNlQhcHK| MojWR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhe3WkLVexJJBp[XOnIHHmeIVzKDJ2IHjyd{B2e2mwZzDwdo9xcWSrdX2gbY9lcWSnIHHu[EBDemSXIIP0ZYlvcW6pIHL5JIZtd3diY4n0c41mfHK7 NVfBTYtSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0NVc1OTdpPkKxOFE4PDF5PD;hQi=>
RPMI8226 MYTD[YxtKGO7Y3zlJIF{e2G7 NVnRSZlYOjRiaILz NVu0[GpbS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWlCPSUiyNlYh[2WubIOgZZN{\XO|ZXSgZZMh[WOldX31cIF1cW:wIHH0JJN2[i2JMTDwbIF{\SCjZoTldkAzPCCqcoOgeZNqdmdicILvdIllcXWvIHnv[Ill\SCjbnSgRpJlXSC|dHHpcolv\yCkeTDmcI94KGO7dH;t[ZRzgQ>? NHntUXo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
MCF7 MmHyR4VtdCCleXPs[UBie3OjeR?= MUC4NEB2VQ>? MXGyOEBpenN? MWPD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDhZ5RqfmWueTDy[ZBtcWOjdHnu[{BFVkFibHX2[Ywh[XRiOECgeW0h[W[2ZYKgNlQhcHK|IIXzbY5oKHC{b4Dp[Il2dSCrb3Tp[IUh[W6mIFLy[HUhe3SjaX7pcoch[nliZnzve{BkgXSxbXX0dpk> MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTRzN{SxO{c,OjF2MUe0NVc9N2F-
MCF7 NIPldmlHfW6ldHnvckBie3OjeR?= MmjSNlAhfU1? NUXOSWdXOjRiaILz MVzJcoR2[3Srb36gc4YheDV|LXTldIVv\GWwdDD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliaX6gbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBw\iCyMkGgW2FHOSCuZY\lcEBifCB{MDD1UUBi\nSncjCyOEBpenNiYomgbY1ufW6xZnz1c5Jme2OnbnPlJIF{e2G7 NHfuTZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUSxO|QyPyd-MkG0NVc1OTd:L3G+
RPMI8226 MoTrR4VtdCCleXPs[UBie3OjeR?= NE\YbZMzPCCqcoO= NIHoXHVE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBTWE2LOEKyOkBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiCVIIDoZZNmKGOnbHygdI9xfWyjdHnvckBi\nSncjCyOEBpenNidYPpcocheHKxcHnkbZVuKGmxZHnk[UBidmRiQoLkWUB{fGGrbnnu[{BjgSCobH;3JIN6fG:vZYTyfS=> MkTRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2MUe0NVcoRjJzNEG3OFE4RC:jPh?=
RPMI8226 NG\TRnpE\WyuIHP5Z4xmKGG|c3H5 MUi4NEB2VQ>? Mn7KNlQhcHK| NUC5epNCS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWlCPSUiyNlYh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKG:oIHHjeIl3\Wy7IILldIxq[2G2aX7nJGRPSSCuZY\lcEBifCB6MDD1UUBi\nSncjCyOEBpenNidYPpcocheHKxcHnkbZVuKGmxZHnk[UBidmRiQoLkWUB{fGGrbnnu[{BjgSCobH;3JIN6fG:vZYTyfS=> MkKxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2MUe0NVcoRjJzNEG3OFE4RC:jPh?=
A549 MmXERZBweHSxc3nzJIF{e2G7 MV[yJJVO MkPBOFghcHK| NVn6OmQ1UW6mdXP0bY9vKG:oIHHwc5B1d3OrczDpckBpfW2jbjDBOVQ6KGOnbHzzJIF{e2W|c3XkJIF{KESQQTDmdoFodWWwdHH0bY9vKGG2IEKgeW0h[W[2ZYKgOFghcHK|IHL5JIFo[XKxc3Wg[4VtKGWuZXP0do9xcG:{ZYPpdy=> M4LXe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NkKzOFkyLz5{M{[yN|Q6OTxxYU6=
Sf9 M3Wyd2Z2dmO2aX;uJIF{e2G7 M4nRd|ExKG2rboO= M1ns[WlvcGmkaYTpc44hd2ZiSHnzMVYufGGpZ3XkJJJm[2:vYnnuZY51KGi3bXHuJGNFUzJxY4njcIlvTSCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMucW6oZXP0[YQhe2Z7IHPlcIx{KHW|aX7nJIhqe3SxbnWgTFEh[XNic4Xid5Rz[XSnIHHmeIVzKDFyIH3pcpMh[nlibHnxeYllKHOlaX70bYxt[XSrb36gZ492dnSrbnegbY4heHKnc3XuZ4Uhd2ZiW3fhcY1iNTN{UG3BWHAtKEmFNUCgQUAxNjFizszNMi=> MomyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2MUe1OlYoRjJ2NEG3OVY3RC:jPh?=
BJ NYOwWGtFTnWwY4Tpc44h[XO|YYm= NYr1UGlDOTBidV2= NXj2Z5FYOTBiZHH5dy=> NXnEeIZtW3WycILld5Nqd25ib3[gd4Vv\XOlZX7j[UBqdiCqdX3hckBDUiClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDj[YxtKG63bXLldkBifCBzMDD1UUBi\nSncjCxNEBl[Xm|IHL5JJNmdmW|Y3XuZ4UhemW4ZYLzZYwh[XO|YYm= NXyxbmhkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2PFE6QDZpPkK0OlgyQTh4PD;hQi=>
BJ NE\DXnJHfW6ldHnvckBie3OjeR?= NHzuW5oyOCC3TR?= NYX6N|hzOTBiZHH5dy=> M4fLTWlvcGmkaYTpc44hd2ZiYYThfIliKHSnbHHu[4lm[3Sjc3nhMY12fGG2ZXSgbY4hcHWvYX6gRmoh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iY3XscEBvfW2kZYKgZZQhOTBidV2gZYZ1\XJiMUCg[IF6eyCkeTDz[Y5me2OnbnPlJJJmfmW{c3HsJIF{e2G7 MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6MUm4Okc,OjR4OEG5PFY9N2F-
MCF7 MU\GeY5kfGmxbjDhd5NigQ>? NYK2THdXOTBidV2= NXvIZnFMOTBibXnudy=> MoPmV4Vve2m2aYrheIlwdiCxZjDpcoZz[XKnZD3pcoR2[2WmIFTORUBl[W2jZ3WgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ49td267IH\vdo1ifGmxbjDheEAyOCC3TTDwdoV1emWjdHXkJIZweiBzMDDtbY5{KG[xbHzve4VlKGK7IHnydoFlcWG2aX;uJIZweiB2IHjyd{Bu\WG|dYLl[EBi\nSncjCxNEBl[Xm|IHL5JINzgXO2YXygeolwdGW2IIP0ZYlvcW6pIHHuZYx6e2m| NX;3RnRMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[4OVE2ODVpPkK2PFUyPTB3PD;hQi=>
Caco2 MnfqR4VtdCCleXPs[UBie3OjeR?= Mke3R4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gR4FkdzJiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEdzL2OgdIhie2ViYomgTI9m[2i|dDDzeIFqdmmwZzDiZZNm\CCobIXvdoV{[2WwY3WgZZN{[Xl? NGfxeGg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
HaCaT MkCzR4VtdCCleXPs[UBie3OjeR?= M2rxNGNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGhiS2GWIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMT;TJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 MoDUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{MUSyN|EoRjJ6MkG0NlMyRC:jPh?=
HuH7 Mn3pR4VtdCCleXPs[UBie3OjeR?= MXjD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDIeWg4KGOnbHzzJIF{e2W|c3XkJIF{KGGlY4XteYxifGmxbjDheEBIOS:VIIDoZZNmKGK7IFjv[YNpe3Ric4ThbY5qdmdiYnHz[YQh\my3b4Lld4NmdmOnIHHzd4F6 MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJzNEKzNUc,Ojh{MUSyN|E9N2F-
PC3 MkTPR4VtdCCleXPs[UBie3OjeR?= NXXL[HR1S2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hWEN|IHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMj;NJJBp[XOnIHL5JGhw\WOqc4Sgd5RicW6rbnegZoF{\WRiZnz1c5Jme2OnbnPlJIF{e2G7 M{LkTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MkG0NlMyLz5{OEKxOFI{OTxxYU6=
MDA-MB-231 NXz6RpZzS2WubDDjfYNt\SCjc4PhfS=> M{ixemNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJG1FSS2PQj2yN|Eh[2WubIOgZZN{\XO|ZXSgZZMh[WOldX31cIF1cW:wIHH0JGcyN1NicHjhd4Uh[nliSH;lZ4h{fCC|dHHpcolv\yCkYYPl[EBndHWxcnXzZ4Vv[2ViYYPzZZk> NIPIXmU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
HCT116 Ml3CR4VtdCCleXPs[UBie3OjeR?= NH3kXnBE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBJS1RzMU[gZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKGG2IFexM3MheGijc3WgZpkhUG:nY3jzeEB{fGGrbnnu[{Bj[XOnZDDmcJVwemW|Y3XuZ4Uh[XO|YYm= NFj1UoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEKxOFI{OSd-MkiyNVQzOzF:L3G+
SK-N-MC NV\YZYs5eUiWUzDhd5NigQ>? NXjjPFV2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NXG4TGlZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki1OVc1OzBpPkK4OVU4PDNyPD;hQi=>
A673 NY\TTYhXeUiWUzDhd5NigQ>? MXjxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? MlXVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
DAOY MnzxdWhVWyCjc4PhfS=> NXf6WnhreUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO= MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 NUfCcmdXeUiWUzDhd5NigQ>? M2jBUJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCEVD2zO{Bk\Wyucx?= MoXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 Mnq5dWhVWyCjc4PhfS=> MX\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= NGnVeGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
LAN-5 NF73[otyUFSVIHHzd4F6 NXTw[Y9xeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFzBUk02KGOnbHzz MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC NH7J[WpyUFSVIHHzd4F6 M13EZZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7OUewNkc,OzBzOUm3NFI9N2F-

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
pT231-tau / pS202-tau / tau; 

PubMed: 30915013     


SH-SY5Y-(P301L) cells were exposed for 6 h to a range of roscovitine concentrations. Cells were harvested and proteins were resolved by SDS-PAGE followed by western blotting.

p-Rb / p-CDK2 / CDK2 / Cyclin D1 / Cyclin A2 / ERα / ERβ/ AIB1 / PELP1 ; 

PubMed: 21834972     


(a) The model cells MCF7, MCF7-TamR, MCF7-HER2, and MCF7-LTLTca were treated with roscovitine and the status of cell cycle regulators and the estrogen receptor (ERα) signaling proteins was analyzed by western blotting. 

30915013 21834972
Immunofluorescence
CDK1 / Smek2 / FUBP1 / Cdc20 ; 

PubMed: 24534090     


A-D Validation of changes in chromatin affinity following Cdk inhibition of indicated candidates (2 h, 50 μM roscovitine) using Triton extraction and immunofluorescence (IF) in HeLa cells. Quantification of IF data was performed by measuring changes in signal intensities in Image J.

E2F1 / FASN / Bmi1 / Cyclin D2 / CDK2 / CDK4 ; 

PubMed: 20890301     


Immunofluorescence analysis of E2F1, FASN, E2F1/Shh target Bmi1, cyclin D2, cdk 2, and cdk 4 in Pzp53med cells treated with DMSO (control) or the cdk inhibitor roscovitine (10 nM) for 18 hours.

24534090 20890301
Growth inhibition assay
Cell viability; 

PubMed: 29996940     


Cell viability assay on OVCAR5, OAW42, SKOV3 and NL3507 cells treated with roscovitine (2, 5, 10, 20, 40 μM) up to 96 h. Each point represents the mean of three replicates. Error bars, SD

29996940
In vivo Roscovitine, at a dose of 50 mg/kg, significantly inhibits growth of The Ewing's sarcoma family of tumors (ESFT) xenografts. [4] Roscovitine enhances the antitumor effect of doxorubicin without increased toxicity with a mechanism that involves cell cycle arrest rather than apoptosis in nude mice bearing established MCF7 xenografts. [5]

Protocol

Kinase Assay:[1]
- Collapse

Enzymes :

Kinases activities are assayed at 30 °C in buffer C. Blank values are subtracted from the data and activities calculated as molar amount of phosphate incorporated in protein acceptor during a 10-minute incubation. Controls are performed with appropriate dilutions of DMSO. In a few cases, phosphorylation of the substrate is assessed by autoradiography after SDS/PAGE. p34cdc2/cyclin B is purified from M-phase starfish (M. glacialis) oocytes by affinity chromatography. It is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP (3000 Ci/mmol; 1 mCi/mL) in a final volume of 30 μL. After a 10-minute incubation at 30 °C, 25-μL aliquots of supernatant are spotted onto pieces of Whatman P81 phosphocellulose paper, and, after 20 seconds, the filters are washed five times (for at least 5 minutes each time) in a solution of 10mL phosphoric acid/L water. The wet filters are transferred into 6-mL plastic scintillation vials, 5 mL ACS scintillation fluid is added and the radioactivity measured in a Packard counter. The kinase activity is expressed as molar amount of phosphate incorporated in histone H1 during a 10-minutes incubation or as a percentage of maximal activity. p33cdk2/cyclin A and p33cdk2/cyclinE are reconstituted from extracts of sf9 insect cells infected with various baculoviruses. Cyclins A and E are fusion proteins with glutathione S-transferase and the complexes are purified on glutathione-agarose beads. Kinase activities are assayed with 1 mg/mL histone H1, in the presence of 15 μM [γ-32P]ATP, during 10 minutes, in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/p35 is purified from bovine brain, excluding the Mono S-chromatographic step. The active fractions from the Superose 12 column are pooled and concentrated to a final concentration of approximately 25 μg enzyme/mL. The kinase is assayed with 1 mg/mL histone HI in the presence of 15 μM [γ-32P]ATP, during 10 minutes in a final volume of 30 μL, as described for the p34cdc2/cyclin B kinase. p33cdk5/cyclin D1 is obtained from insect cell lysates. Cdk4 is a fusion protein with glutathione-S-transferase and the active complex is purified on glutathione-agarose beads. Its kinase activity is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. After a 15-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10 % SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. p33cdk4/cyclinD 2 is obtained from insect cell lysates. It is assayed with purified retinoblastoma protein (complexed with glutathione-S-transferase) in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. After a 30-minute incubation, 30 μL Laemmli sample buffer is added. The phosphorylated substrate is resolved by 10% SDS/PAGE and analysed by autoradiography by overnight exposure to Hyperfilm MP and densitometry. MAP kinase erkl (tagged with glutathione-S-transferase), is expressed in bacteria, purified on glutathione-agarose beads and assayed with 1 mg myelin basic protein/ml in the presence of 15 μM [γ-32P]ATP as described above for the p34cdc2cyclin B kinase. His-tagged erkl and erk2 are activated in vitro by mitogen-activated protein kinase kinase, purified (Ni-affinity and Mono Q) and assayed as described above during 10 minutes in a final volume of 30 μL. Protein kinase C isoforms are purified from baculovirus infected sf9 insect cells and assayed with 1 mg/mL protamine sulfate in the presence of 15 μM [γ-32P]ATP, during 10 minutes at 30 °C, in a final volume of 30 μL. Phosphorylated protamine sulfate is recovered on Whatman P81 phosphocellulose paper as described for the cdc2 kinase. The catalytic subunit of cAMP-dependent protein kinase, purified from bovine heart, is assayed with 1 mg histone Hl/ml, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. cGMP-dependent protein kinase, purified to homogeneity from bovine tracheal smooth muscle, is assayed with 1 mg histone Hl/mL, in the presence of 15 μM [γ-32P]ATP as described for the p34cdc2/cyclin B kinase. Casein kinase 2 is isolated from rat liver cytosol and assayed with 1 mg casein/mL and 15 μM [γ-32P]ATP. The substrate is spotted on Whatmann 3MM filters and washed with 10% (mass/vol.) trichloroacetic acid. Myosin light chain kinase, purified from chicken gizzard is assayed in the presence of 100 nM calmodulin, 100 μM CaCl2, 50 mM Hepes, 5 mM MgCI,, 1 mM dithiothreitol and 0.1 mg BSA/ml at pH 7.5 using a synthetic peptide based on the smooth-muscle myosin light-chain phosphorylation site and in the presence of 15 μM [γ-32P]ATP, in a final volume of 50 μL. Incorporation of radioactive phosphate is monitored on phosphocellulose filters as described above. ASK-γ, a plant homologue of GSK-3, is expressed as a glutathione-S-transferase fusion protein in Escherichia coli and purified on glutathione-agarose. ASK-γ kinase is assayed, for 10 minutes at 30 °C, with 5 μg myelin basic protein, in the presence of 15 μM [γ-32P]ATP in a final volume of 30 μL. The phosphorylated myelin basic protein is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. Insulin receptor tyrosine kinase domain (CIRK-41) is overexpressed in a baculovirus system and purified to homogeneity. Its kinase activity is assayed, for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase. c-src kinase is purified from infected Sf9 cells. The v-abl kinase is expressed in E. coli and affinity purified on IgG Affigel 10. Both kinases are assayed for 10 minutes at 30 °C, with 5 μg Raytide, in the presence of 15 μM [γ-32P]ATP, in a final volume of 30 μL. The phosphorylated Raytide is recovered on Whatman P81 phosphocellulose paper as described for the p34cdc2/cyclin B kinase.
Cell Research:[1]
- Collapse
  • Cell lines: Leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, breast cancer
  • Concentrations: 0.01 - 100 μM
  • Incubation Time: 48 hours
  • Method: 60 human tumour cell lines comprising nine tumor types are cultured for 24 hours prior to a 48-hour continuous exposure to 0.01-100 μM roscovitine. A sulforhodaminine B protein assay is used to estimate the cytotoxicity.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: A4573 cells are injected s.c. into the right posterior flank of CD1 nu/nu mice.
  • Dosages: ≤50 mg/kg
  • Administration: Administered via i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 71 mg/mL (200.31 mM)
Water Insoluble
Ethanol ''6 mg/mL
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+69% PEG 400
For best results, use promptly after mixing.
5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 354.45
Formula

C19H26N6O

CAS No. 186692-46-6
Storage powder
in solvent
Synonyms Seliciclib, R-roscovitine
Smiles CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02649751 Terminated Drug: Roscovitine|Drug: Placebo Cystic Fibrosis University Hospital Brest|ManRos Therapeutics|Cyclacel Pharmaceuticals Inc. February 22 2016 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How can I reconstitute the drug for in vivo studies?

  • Answer:

    S1153 in 1% DMSO+10% Tween 80+20% N-N-dimethylacetamide+PEG 400 is a clear solution which is okay for injection. And S1153 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30mg/ml is a suspension, which is fine for oral gavage.

CDK Signaling Pathway Map

CDK Inhibitors with Unique Features

Related CDK Products

Tags: buy Roscovitine (CYC202) | Roscovitine (CYC202) supplier | purchase Roscovitine (CYC202) | Roscovitine (CYC202) cost | Roscovitine (CYC202) manufacturer | order Roscovitine (CYC202) | Roscovitine (CYC202) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID